Kruger, T. M., Valenzuela, B., Thompson, C. D., Ouwerkerk-Mahadevan, S., & Ruixo, J. J. P. (2023). Clinical Pharmacokinetics of Ponesimod, a Selective S1P1 Receptor Modulator, in the Treatment of Multiple Sclerosis. Clinical Pharmacokinetics, 62(11), 1533-1550. https://doi.org/10.1007/s40262-023-01308-5

Kruger, Terra M., Belén Valenzuela, Charles D. Thompson, Sivi Ouwerkerk-Mahadevan, and Juan Jose Perez Ruixo. "Clinical Pharmacokinetics of Ponesimod, a Selective S1P1 Receptor Modulator, in the Treatment of Multiple Sclerosis." Clinical Pharmacokinetics 62, no. 11 (2023): 1533-1550. https://doi.org/10.1007/s40262-023-01308-5.

Kruger, Terra M., et al. "Clinical Pharmacokinetics of Ponesimod, a Selective S1P1 Receptor Modulator, in the Treatment of Multiple Sclerosis." Clinical Pharmacokinetics, vol. 62, no. 11, 2023, pp. 1533-1550, https://doi.org/10.1007/s40262-023-01308-5.